On the Spectrum
2lm5UyR
2lm5UyR
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 8<br />
diseases, according to <strong>the</strong> unique disease principle (Ogino, Lochhead, Chan, Nishihara, Cho et<br />
al. 2013), it is probably even more true in ASD. ASD is especially heterogeneous in its genetic<br />
background, likely forming a mixture of polygenic and monogenic causes, both common and<br />
very rare. To some extent, <strong>the</strong>se diverse genetic backgrounds may converge in overlapping<br />
brain endophenotypes, while some o<strong>the</strong>r pathways may be completely distinct. The brain<br />
networks underlying social functioning are so complex that a plethora of disruptions, caused<br />
by different genes and acting on different levels, could likely lead to ASD-like phenotypes.<br />
Small neuroimaging studies of patients with ASD are difficult to compare, as <strong>the</strong>y likely sample<br />
<strong>the</strong>se different genetic causes of ASD in various proportions. This mixture of pathways could<br />
partly underlie <strong>the</strong> inconsistency in results between such neuroimaging studies, through a<br />
phenomenon called ‘molecular confounding’ (Nishihara, VanderWeele, Shibuya, Mittleman,<br />
Wang et al. 2015), or bias caused by unmeasured subtypes of <strong>the</strong> disease. In many cases,<br />
this cannot be tested, as <strong>the</strong> specific genetic background of ASD is often unknown on <strong>the</strong><br />
individual level. However, some studies of brain development have considered genetic<br />
background. For example, in <strong>the</strong> case of brain growth in <strong>the</strong> first few postnatal years, it has<br />
been shown that <strong>the</strong> growth patterns differ between children from simplex and multiplex<br />
families: a positive association of autistic symptoms with HC was found only in children with<br />
ASD classified as simplex and not in children with ASD from multiplex families (Davis, Keeney,<br />
Sikela and Hepburn 2013). Similarly, ano<strong>the</strong>r study showed that children with autistic traits in<br />
<strong>the</strong> context of Klinefelter syndrome show different localizations of white matter abnormalities<br />
compared to children with idiopathic ASD (Goddard, van Rijn, Rombouts and Swaab 2015).<br />
Ultimately however, it is highly unlikely that studies of ASD will ever be fully stratified by<br />
distinct and homogeneous genetic background, considering <strong>the</strong> sheer multitude of variants<br />
and genetic interactions that can cause ASD in an individual. Clinical studies of sufficiently<br />
large sample size, while undoubtedly comprising different pathways to ASD, can still be useful<br />
in identifying common brain pathways.<br />
Phenotypical heterogeneity<br />
In <strong>the</strong> previous section, we explored <strong>the</strong> genetic heterogeneity of ASD. However, <strong>the</strong>re<br />
is also clear heterogeneity on <strong>the</strong> phenotypic level. For instance, children with ASD can<br />
show normal intelligence, but ASD also frequently occurs in combination with intellectual<br />
disability. It is ra<strong>the</strong>r intuitive to assume that this phenotypic heterogeneity could also be<br />
an obstacle to finding one underlying neurobiology, as children with different characteristics<br />
may show distinct differences in <strong>the</strong>ir brains. A way to deal with this problem involves <strong>the</strong><br />
identification of phenotypical subtypes with similar clinical characteristics. Indeed, many<br />
attempts have been made at this. Most notably, <strong>the</strong> DSM-IV included a sub-classification<br />
that included “Asperger syndrome”, a group of individuals with good language ability and<br />
normal to above-normal IQ, despite initial developmental delays. However, after intensive<br />
198